文献速递免疫规划卫生政策与健康促进

法国青少年人乳头瘤病毒(HPV)疫苗接种覆盖率:一项理赔数据研究

Human Papillomavirus (HPV) vaccination coverage among French adolescents: A claims data study.
PubMed 文献 · Vaccine · 2024-06-08

本研究利用理赔数据描述法国2017至2022年HPV疫苗接种覆盖率变化,部分接种定义为至少发放一剂疫苗,完整接种按法国现行建议定义为18个月内两剂或三剂。结果显示女孩累计接种率上升但2022年仍不足,男孩接种起步初步但前景可期。

要点

  • 2017至2022年间共有1,773,900名女性和592,167名男性启动HPV疫苗接种。
  • 女性11-14岁启动接种占67.3%,男性占62.4%,前两剂中位间隔分别为195天和190天。
  • 2022年女孩15岁时部分接种累计率从2017年28.1%升至50.9%,16岁时完整接种累计率从15.5%升至33.8%。

核心结论

  • 2017至2022年间目标女孩HPV疫苗接种覆盖率上升但仍不足,男孩接种呈现初步但 promising 的起步。

研究设计与样本

  • 基于理赔数据的观察性研究,描述2017至2022年法国人群年度HPV疫苗接种覆盖率。

主要发现

  • 2017至2022年共1,773,900名女性和592,167名男性启动HPV疫苗接种。
  • 女性67.3%和男性62.4%在11至14岁间启动接种,前两剂中位间隔分别为195天和190天。
  • 女孩15岁时部分接种累计率从2017年28.1%升至2022年50.9%。
  • 女孩16岁时完整接种累计率从2017年15.5%升至2022年33.8%。
  • 2022年男性14岁启动率为12.6%,19岁启动率为1.9%。

关键数值与推荐

  • 部分接种定义为至少发放一剂HPV疫苗。
  • 完整接种按法国现行建议定义为18个月内两剂或三剂HPV疫苗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The French cancer control strategy 2021-2030 aims to achieve 80 % human papillomavirus (HPV) vaccination coverage. Since 2021, HPV vaccination is also recommended for boys aged 11-14 years, with a catch-up vaccination recommended for unvaccinated adolescents aged ≤19 years. The PAPILLON study used claims data to monitor the evolution of HPV Vaccination Coverage Rate (VCR) in the French population. METHODS: The annual HPV VCR was described from 2017 to 2022. Partial vaccination was defined as the dispensing of at least one dose of HPV vaccination. Full scheme vaccination was defined according to the current French recommendations as two or three doses of HPV vaccine over an 18-month period. Annual HPV vaccine initiation rates were estimated on 11-14 and 15-19-year-olds adolescents. Cumulative VCR were estimated on adolescents aged between 11 and 19 years at the time of first vaccination. RESULTS: Overall, 1,773,900 females and 592,167 males initiated HPV vaccination between 2017 and 2022. Initiations occurred between 11 and 14 years for 67.3 % of females and 62.4 % of males with a median time between the first two doses of 195 days and 190 days, respectively. In girls, the cumulative vaccination rate for the partial scheme vaccination at 15 y.o. increased from 28.1 % in 2017 to 50.9 % in 2022. Similarly, the cumulative vaccination rate for the full scheme vaccination at 16 y.o. increased from 15.5 % in 2017 to 33.8 % in 2022. In 2022, the initiation rates for males were 12.6 % at age 14 and 1.9 % at age 19. CONCLUSIONS: HPV vaccination coverage increased between 2017 and 2022 among girls targeted by the recommendation but remains insufficient. The results of this study show a tentative but promising start to vaccination in boys. This study will monitor the effects of actions taken to improve vaccination, including the extension of vaccination competencies to community pharmacists since end of 2022.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. de Pouvourville G, Guyot E, Farge G, et al. Human Papillomavirus (HPV) vaccination coverage among French adolescents: A claims data study. Vaccine. 2024. PMID: 38852035. doi:10.1016/j.vaccine.2024.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。